CTOs on the Move

Health IQ

www.healthiq.com

 
At Health IQ, we believe the best way to improve the health of the world is to celebrate the health conscious rather than harassing those who are not.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.healthiq.com
  • 2513 Charleston Rd #102
    Mountain View, CA USA 94043
  • Phone: 800.549.1664

Executives

Name Title Contact Details

Funding

Health IQ raised $34.6M on 11/15/2017
Health IQ raised $55M on 05/08/2019

Similar Companies

Titan Instruments

Titan Instruments is a Hamburg, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accra Home Care

For 30 years, Accra has improved the lives of Minnesotans by providing individualized homecare services to people with disabilities and older adults, most of whom are Medicaid enrollees. Accra is a nonprofit organization that operates in all counties throughout Minnesota and has offices across the state, providing a familiar presence in local communities. Accra`s self-directed services support the independence of children, adolescents, and adults with disabilities, chronic diseases, behavioral diagnoses, and mental illnesses, who need assistance with personal care in the home and activities of daily living.

BDI Pharma

BDI Pharma is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.